March 28, 2017: Interesting Interview: CEO Jon Dou
Post# of 15624
@ 8:00
Talking about the big potential with bio-pharma pre-revenue companies with great management, scientists and business model can reach $1B valuation.
@ 9:00
CEO Jon Doukas is flying to Tel-Aviv next week to look at a bio-pharma deal (he mentioned cannabis!) with some of the greatest scientists in Israel who have been doing research for 20 years.
https://upticknewswire.com/ceo-jon-doukas-tre...listeners/